2Kawanami R,Kawamura T,Nakahara Y,et al.Succe-ssful treatment of allergic bronchopulmonary aspergillosis with erythromycin and fluconazole[J].Nihon Kokyuki Gakkai Zasshi,1999,37(4): 327-332.
3Nonaka M,Pawankar R,Tomiyama S,et al.A macrolide anti-biotic,roxithromycin,inhibits the growth of nasal polyp fibroblasts[J].Am J Rhinol,1999,13(4): 267-272.
4Cervin A,Kalm O,Sandkull P,et al.One-year low-dose erythro-mycin treatment of persistent chronic sinusitis after sinus surgery: clinical outcome and effects on mucociliary parameters and nasal nitric oxide[J].Otolaryngol Head Neck Surg,2002 ,126(5): 481-489.
5Linoy Y,Sugita K,Toryama M,et al.Erythromycin thr-apy fortitis me-dia with effusion in sinobronchial syndrome[J].Arch Otolaryngol Head Neck Surg,1993,119(6):643-651.
6Daian C M,Wolff A H,Bielory L.The role of atypical organisms in asthma[J].Allergy Asthma Proc,2000,21(2): 107-111 .
7Takamura M,Odashima Y,Iikura H.Continuous low-dosage macro-lide therapy in children with bronchial asthma[J].Jpn J Antibiot,2001 ,54 (Suppl C): 9-11.
8Ekici A,Ekici M,Erdemoglu A K.Effect of azith-romycin on the severity of bronchial hyperresponsiveness in patients with mild asthma[J].J Asthma,2002 ,39(2): 181-185.
9Derelle J.Anti-inflammatory therapy in cystic fibrosis[J].Arch Pe-diatr,2003,10 (Suppl 2): 370-375.
10Ekici A,Ekici M,Erdemoglu A K.Effect of azithr-omycin on the severity of bronchial hyperresponsiveness in patients with mild asthma[J].J Asthma,2002 ,39(2):181-185 .
